David A Kalmbach1, Philip Cheng2, Louise M O'Brien3, Leslie M Swanson4, Roopina Sangha5, Srijan Sen4, Constance Guille6, Andrea Cuamatzi-Castelan2, Alasdair L Henry7, Thomas Roth2, Christopher L Drake2. 1. Thomas Roth Sleep Disorders & Research Center, Henry Ford Health System, Detroit, MI, USA. Electronic address: dkalmba1@hfhs.org. 2. Thomas Roth Sleep Disorders & Research Center, Henry Ford Health System, Detroit, MI, USA. 3. Departments of Obstetrics & Gynecology and Neurology, University of Michigan, Ann Arbor, MI, USA. 4. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. 5. Department of Obstetrics & Gynecology, Henry Ford Health System, Detroit, MI, USA. 6. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA. 7. Big Health Inc, San Francisco, CA, USA; Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Abstract
OBJECTIVE: Despite high rates of prenatal insomnia, efficacious treatment options for this population are quite limited. Early evidence from randomized controlled trials (RCTs) support the efficacy of face-to-face cognitive-behavioral therapy for insomnia (CBTI) for prenatal insomnia. Yet, as many patients are unable to access this specialist-driven care, a critical need exists to increase its accessibility. This RCT examined the efficacy internet-based digital CBTI in pregnant women with insomnia. METHODS: Single-site RCT. A total of 91 pregnant women (29.03 ± 4.16 years) nearing/entering the third trimester who screened positive for clinical insomnia on the Insomnia Severity Index (ISI) were randomized to digital CBTI or digital sleep education control. The ISI, Pittsburgh Sleep Quality Index (PSQI), Edinburgh Postnatal Depression Scale (EPDS), and Pre-Sleep Arousal Scale's Cognitive factor (PSAS-C) served as study outcomes, which were collected before treatment and after treatment during pregnancy, then six weeks after childbirth. RESULTS: From pre to posttreatment, CBTI patients reported reductions in ISI (-4.91 points, p < 0.001) and PSQI (-2.98 points, p < 0.001) and increases in nightly sleep duration by 32 min (p = 0.008). Sleep symptoms did not change during pregnancy in the control group. After childbirth, CBTI patients, relative to controls, slept longer by 40 min per night (p = 0.01) and reported better sleep maintenance. No pre or postnatal treatment effects on depression or cognitive arousal were observed. CONCLUSIONS:Digital CBTI improves sleep quality and sleep duration during pregnancy and after childbirth. To better optimize outcomes, CBTI should be tailored to meet the changing needs of women as the progress through pregnancy and early parenting. NAME: Insomnia and Rumination in Late Pregnancy and the Risk for Postpartum Depression. URL: clinicaltrials.gov. Registration: NCT03596879.
RCT Entities:
OBJECTIVE: Despite high rates of prenatal insomnia, efficacious treatment options for this population are quite limited. Early evidence from randomized controlled trials (RCTs) support the efficacy of face-to-face cognitive-behavioral therapy for insomnia (CBTI) for prenatal insomnia. Yet, as many patients are unable to access this specialist-driven care, a critical need exists to increase its accessibility. This RCT examined the efficacy internet-based digital CBTI in pregnant women with insomnia. METHODS: Single-site RCT. A total of 91 pregnant women (29.03 ± 4.16 years) nearing/entering the third trimester who screened positive for clinical insomnia on the Insomnia Severity Index (ISI) were randomized to digital CBTI or digital sleep education control. The ISI, Pittsburgh Sleep Quality Index (PSQI), Edinburgh Postnatal Depression Scale (EPDS), and Pre-Sleep Arousal Scale's Cognitive factor (PSAS-C) served as study outcomes, which were collected before treatment and after treatment during pregnancy, then six weeks after childbirth. RESULTS: From pre to posttreatment, CBTIpatients reported reductions in ISI (-4.91 points, p < 0.001) and PSQI (-2.98 points, p < 0.001) and increases in nightly sleep duration by 32 min (p = 0.008). Sleep symptoms did not change during pregnancy in the control group. After childbirth, CBTIpatients, relative to controls, slept longer by 40 min per night (p = 0.01) and reported better sleep maintenance. No pre or postnatal treatment effects on depression or cognitive arousal were observed. CONCLUSIONS:Digital CBTI improves sleep quality and sleep duration during pregnancy and after childbirth. To better optimize outcomes, CBTI should be tailored to meet the changing needs of women as the progress through pregnancy and early parenting. NAME: Insomnia and Rumination in Late Pregnancy and the Risk for Postpartum Depression. URL: clinicaltrials.gov. Registration: NCT03596879.
Authors: Rachel Manber; Rebecca A Bernert; Sooyeon Suh; Sara Nowakowski; Allison T Siebern; Jason C Ong Journal: J Clin Sleep Med Date: 2011-12-15 Impact factor: 4.062
Authors: Julio Fernandez-Mendoza; Michele L Shaffer; Sara Olavarrieta-Bernardino; Alexandros N Vgontzas; Susan L Calhoun; Edward O Bixler; Antonio Vela-Bueno Journal: J Sleep Res Date: 2014-05-30 Impact factor: 3.981
Authors: Vivek Pillai; Jason R Anderson; Philip Cheng; Luisa Bazan; Sophie Bostock; Colin A Espie; Thomas Roth; Christopher L Drake Journal: J Sleep Med Disord Date: 2015-02-23
Authors: Alexandria Muench; Ivan Vargas; Michael A Grandner; Jason G Ellis; Donn Posner; Célyne H Bastien; Sean Pa Drummond; Michael L Perlis Journal: Fac Rev Date: 2022-02-01
Authors: Bei Bei; Donna M Pinnington; Nina Quin; Lin Shen; Michelle Blumfield; Joshua F Wiley; Sean P A Drummond; Louise K Newman; Rachel Manber Journal: Psychol Med Date: 2021-07-07 Impact factor: 7.723